SEATTLE--(BUSINESS WIRE)--According to Coherent Market Insights, the global dextrose injection market is estimated to be valued at US$ 9,512.7 million in 2020 and is expected to exhibit a CAGR of 5.7% ...

New clinical data suggests intra-articular injections of hypertonic dextrose are safe and effective at alleviating knee pain caused by osteoarthritis, a condition affecting nearly 30 million Americans ...

Amphastar Pharmaceuticals announced that the US Food and Drug Administration (FDA) has approved its Abbreviated New Drug Application (ANDA) for Dextrose injection 50% in the 50 ml Luer-Jet Prefilled ...

Hikma is offering labetalol hydrochloride 1mg/mL in 200-ml dextrose injection and 100-, 200- and 300-mL in sodium chloride injection. Labetalol HCl in sodium chloride injection and labetalol HCl in ...

RANCHO CUCAMONGA, Calif., March 29, 2021 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the U.S. Food and Drug Administration (“FDA”) approved the Company’s ...

Hikma is offering clindamycin in 5% dextrose injection, in 300mg/50ml, 600mg/50ml and 900mg/50ml doses. The product is available in a vial. Clindamycin in 5% dextrose injection is indicated for the ...

After Baxter International temporarily closed its North Cove facility in Marion, N.C., the company told customers in an Oct. 3 email to evaluate their inventory of several saline, dextrose and ...

SterRx, LLC today announced the voluntary nationwide recall of three lots of Sodium Bicarbonate in 5% Dextrose Injection 150mEq per 1,000 mL due to waterborne microbial contamination. SterRx, LLC has ...

Deerfield, Ill.-based Baxter International has issued a voluntary recall of certain lots of its 5% Dextrose Injection and 0.9% Sodium Chloride Injection due to particulate matter in the solution. If ...